The non-therapeutic biomolecules market size is witnessing significant growth, with its value moving from $30.76 billion in 2024 to $34.23 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. This impressive growth is chiefly driven by increased research and development (R&D) investments, growing applications in research and diagnostics, rising awareness and adoption, strong strategic collaborations and partnerships, and favorable regulatory support.
The market size is expected to continually expand over the next few years, reaching $52.15 billion in 2029 at a CAGR of 11.1%. The expansion in the forecast period is attributed to emerging market opportunities, advancements in data analytics and integration, growing focus on precision medicine, increasing investment in personalized healthcare, and expanding application areas. Key trends include technological advancements, strategic collaborations, rising applications in agriculture, and expanding role in industrial processes.
Get Your Free Sample of The Global Non-Therapeutic Biomolecules Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp
What Are The Key Drivers In The Non-Therapeutic Biomolecules Market?
The rapid surge in the number of research activities and laboratory tests is the key driver propelling the growth of the non-therapeutic biomolecules market. Non-therapeutic biomolecules in laboratory testing are deployed to measure the presence or concentration of a biomarker molecule that indicates disease, which enhances the sensitivity and specificity of the test. Diagnostic activity has seen a spectacular increase, passing pre-pandemic levels in 2023, with a 21% rise in tests performed in May 2024 compared to the previous year.
What are the Key Segments in the Non-Therapeutic Biomolecules Market?
• By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
• By End User: Research, Pharma, In Vitro Diagnostics(IVD)
Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report
Who are the Major Players in the Non-Therapeutic Biomolecules Market?
The major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.
What Trends Are Emerging in the Non-Therapeutic Biomolecules Market?
Product innovations stand out as a significant trend in the non-therapeutic biomolecules market. Major companies operating in the market are heavily invested in research and development for product innovations to reaffirm their market position.
Which Region is Leading in the Non-Therapeutic Biomolecules Market?
Asia-Pacific leads in the non-therapeutic biomolecules market share as of 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Non-Therapeutic Biomolecules Market Report 2025 Offer?
Non-therapeutic biomolecule refers to the organic compounds created by cells and living things. These compounds perform a wide range of tasks in body functioning. The Non-Therapeutic Biomolecules Market research report from The Business Research Company provides global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8769
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Read Related Topics:
https://goodprnews.com/vertical-lift-module-market-trends/
https://goodprnews.com/viral-inactivation-market-trends/
https://goodprnews.com/whole-exome-sequencing-market-trends/
https://goodprnews.com/steel-wire-rope-and-plastic-rope-market-trends/
https://goodprnews.com/telecom-operations-management-market-trends/
https://goodprnews.com/unmanned-surface-vehicle-usv-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model